510(k) K222148
K222148 is an FDA 510(k) premarket notification submitted by Pixcell Medical Technologies, Ltd. for the device "HemoScreen Hematology Analyzer". The FDA issued a decision of Substantially Equivalent on August 16, 2023. The device falls under product code GKZ (Counter, Differential Cell), a Class II device regulated under 21 CFR 864.5220. Pixcell Medical Technologies, Ltd. has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 16, 2023
- Date Received
- July 20, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Counter, Differential Cell
- Device Class
- Class II
- Regulation Number
- 864.5220
- Review Panel
- HE
- Submission Type